List of works - Srilatha Edupuganti

2492. Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients

scholarly article by Hana M El Sahly et al published November 2018 in Open Forum Infectious Diseases

A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity

scientific article published on 3 December 2012

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

scientific article

Biphasic Zika Illness With Rash and Joint Pain

scientific article published on 22 June 2017

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

scientific article

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

scientific article published on 7 February 2011

Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood

article

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

scientific article published on July 2015

Cytotoxic T-lymphocyte responses to canarypox vector-based HIV vaccines in HIV-seronegative individuals: a meta-analysis of published studies

scientific article

DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial

scientific article published on 7 May 2015

Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination

scientific article

Enrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever Vaccine.

scientific article

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).

scientific article published on 5 June 2015

Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification

scientific article

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

scientific article

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines

scientific article

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons

scientific article

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial

scientific article published on October 2014

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

scientific article

Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination

scientific article

Innate, T and B Cell Responses in Acute Human Zika Patients

scientific article published on 17 August 2017

Origin and differentiation of human memory CD8 T cells after vaccination

scientific article published on 13 December 2017

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

scientific article

Pericarditis Associated With Acute Zika Virus Infection in a Returning Traveler

scientific article

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

scientific article

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

scientific article

Rapid generation of neutralizing antibody responses in COVID-19 patients

scientific article published on 08 May 2020

Recognition of influenza H3N2 variant virus by human neutralizing antibodies

scientific article published on July 2016

Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas

scientific article

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

scientific article

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery

scientific article published on 08 July 2013

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults

scientific article published on January 2009

Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant

scientific article published on 31 January 2011

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

scientific article published on 4 December 2017

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial

scientific article published on October 2014

Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1

scientific article

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

scientific article

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

scientific article published on 01 June 2020

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response

scientific article

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial

scientific article

List of works by Srilatha Edupuganti

2492. Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients

A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

Biphasic Zika Illness With Rash and Joint Pain

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

Cytotoxic T-lymphocyte responses to canarypox vector-based HIV vaccines in HIV-seronegative individuals: a meta-analysis of published studies

DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial

Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination

Enrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever Vaccine.

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).

Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination

Innate, T and B Cell Responses in Acute Human Zika Patients

Origin and differentiation of human memory CD8 T cells after vaccination

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

Pericarditis Associated With Acute Zika Virus Infection in a Returning Traveler

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

Rapid generation of neutralizing antibody responses in COVID-19 patients

Recognition of influenza H3N2 variant virus by human neutralizing antibodies

Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults

Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial

Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial